Marzetti is trading at $103.00 (-7.15%) in pre-market after adjusted Q1 EPS missed estimates.

  • It reported adjusted Q1 EPS of $1.14, below the $1.36 estimate.
  • Before results, analysts expected $1.37 EPS and had flagged lingering Cyclospora-related pressure on retail sales.
  • The report was scheduled before the November 3 market open; no pre-market volume information was provided.